NCT06226753

Brief Summary

Randomized, Interventional ,Open labeled, Parallel Assignment and Superiority trial.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 3, 2024

Completed
23 days until next milestone

First Posted

Study publicly available on registry

January 26, 2024

Completed
6 days until next milestone

Study Start

First participant enrolled

February 1, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

February 2, 2024

Status Verified

February 1, 2024

Enrollment Period

1.3 years

First QC Date

January 3, 2024

Last Update Submit

February 1, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Time to passage of flatus

    Time to passage of first flatus from the time of patient leaving operating room up to 72 hours after surgery will be estimated in hours

    Up to 72 hours after surgery

Secondary Outcomes (3)

  • Time to passage of motions

    Up to 1 week after surgery

  • Time taken to resumption of oral intake

    Up to 72 hours after surgery

  • Time of complete stoppage of IV fluids

    Up to 72 hours after surgery

Other Outcomes (11)

  • Postoperative mean Numerical Rating Score

    At 6,12 and 24 hours

  • Time to need 1st injectable rescue analgesic i.e. Tramadol

    Up to 72 hours after surgery

  • Total number of doses of rescue analgesic used

    Up to 1 week after surgery

  • +8 more other outcomes

Study Arms (2)

Stoma reversal under GA

ACTIVE COMPARATOR

Loop ileostomy closure will be performed under General anaesthesia

Procedure: Type of anaesthesia used

Stoma reversal under SA

EXPERIMENTAL

Loop ileostomy closure will be performed under Spinal anaesthesia

Procedure: Type of anaesthesia used

Interventions

Spinal anaesthesia will be used for closure of loop ileostomy

Also known as: ERAS
Stoma reversal under GAStoma reversal under SA

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age of the patient ;18 years
  • Patients with Loop stoma, Double Barrel Stoma or End stoma with
  • documented hitched distal loop.
  • Patients evaluated and fit for surgery

You may not qualify if:

  • Patients requiring mid line laparotomy for stoma reversal
  • Patient having active stoma related complications like high output stoma
  • and dehydration - Acute Kidney Injury, stoma prolapse, etc making them
  • unfit for surgery.
  • Patient denying consent for SA or ERAS protocol
  • Patient having contraindication for either type of anaesthesia (where
  • randomisation would not be possible)
  • Patient needing to be converted to GA after pain /discomfort experienced
  • by patient or if there was failed spinal anaesthesia
  • Patient having abnormal coagulation profile
  • Coexistent neurological or psychiatric illness or unable to understand the
  • study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

All India Institute of Medical Sciences,

Bhubaneswar, Odisha, 751020, India

Location

Study Officials

  • Tushar S Mishra, MBBS MS

    AIIMS Bhubaneswar

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tushar S Mishra, MBBS MS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Allocation: Randomized. Intervention Model: Open labeled, Parallel Assignment, Superiority trial.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 3, 2024

First Posted

January 26, 2024

Study Start

February 1, 2024

Primary Completion

June 1, 2025

Study Completion

June 1, 2025

Last Updated

February 2, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations